secwatch.observer — SEC 8-K summary
======================================

Issuer:     VERACYTE, INC. (VCYT)
CIK:        0001384101
Form:       8-K
Filed at:   2021-08-03T23:59:59+00:00
Accession:  0001384101-21-000141
Event type: m_and_a
Sentiment:  positive
Materiality: 0.75
Item codes: 2.01, 3.02
LLM model:  deepseek-v4-flash:cloud@v2

Veracyte completes €260M acquisition of HalioDx in cash and stock
-----------------------------------------------------------------

- Total consideration €260M: ~€147M cash + ~€113M in Veracyte common stock.
- Acquisition of HalioDx, a French immuno-oncology diagnostics company.
- Closing on August 2, 2021, as previously announced June 1 and July 13.
- Stock consideration issued as unregistered securities under Item 3.02.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1384101/000138410121000141/0001384101-21-000141-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1384101/000138410121000141/vcyt-20210802.htm
  HTML page:      https://secwatch.observer/filing/0001384101-21-000141

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer